TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma
eLife · 2024
DOI: 10.7554/elife.92741 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Maojin Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Translational Medicine, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, China. Hauptthemen laut MEDLINE: Glycolysis, Melanoma, Hypoxia-Inducible Factor 1, alpha Subunit, Neoplastic Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Taishan Young Scholar Foundation of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
TIPE ( TNFAIP8 ) has been identified as an oncogene and participates in tumor biology. However, how its role in the metabolism of tumor cells during melanoma development remains unclear. Here, we demonstrated that TIPE promoted glycolysis by interacting with pyruvate kinase M2 (PKM2) in melanoma. We found that TIPE-induced PKM2 dimerization, thereby facilitating its translocation from the cytoplasm to the nucleus. TIPE-mediated PKM2 dimerization consequently promoted HIF-1α activation and glycolysis, which contributed to melanoma progression and increased its stemness features. Notably, TIPE specifically phosphorylated PKM2 at Ser 37 in an extracellular signal-regulated kinase (ERK)-dependent manner. Consistently, the expression of TIPE was positively correlated with the levels of PKM2 Ser37 phosphorylation and cancer stem cell (CSC) markers in melanoma tissues from clinical samples and tumor bearing mice. In summary, our findings indicate that the TIPE/PKM2/HIF-1α signaling pathway plays a pivotal role in promoting CSC properties by facilitating the glycolysis, which would provide a promising therapeutic target for melanoma intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Translational Medicine, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, China.
- Shandong First Medical University, Jinan, China.
- The Second Medical College, Xinjiang Medical University, Urumqi, China.
- School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China.
ORCID-Profile: Maojin Tian, Peiqing Zhao
Förderung
- National Natural Science Foundation of China
- Taishan Young Scholar Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
- Medicine and Health Science Technology Development Projects of Shandong Province
- Xinjiang Uygur Autonomous Region Training Program of Innovation and Entrepreneurship for College Students
Zitieren
APA
Tian, M., Yang, L., Zhao, Z., Li, J., Wang, L., Yin, Q., Hu, W., Lou, Y., Du, J., & Zhao, P. (2024). TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma. eLife. https://doi.org/10.7554/elife.92741
Vancouver
Tian M, Yang L, Zhao Z, Li J, Wang L, Yin Q, et al. TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma. eLife. 2024. doi:10.7554/elife.92741
BibTeX
@article{Tian2024,
author = {Tian, Maojin and Yang, Le and Zhao, Ziqian and Li, Jigang and Wang, Lianqing and Yin, Qingqing and Hu, Wei and Lou, Yunwei and Du, Jianxin and Zhao, Peiqing},
title = {TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.92741}
}
EUVIMED